Bowman lecture on the role of inflammation in degenerative disease of the eye

Eye (Basingstoke)

Volumn 27, Issue 3, 2013, Pages 340-352

  Forrester, J V ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

angiogenesis; diabetic retinopathy; inflammation; macrophages; macular degeneration; uveitis

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; FIBRIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 8; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 4;

AGING; CELL PROLIFERATION; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DIABETIC RETINOPATHY; DISEASE COURSE; DRUSEN; ENDOCYTOSIS; EYE DISEASE; FIBRINOLYSIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MICROANEURYSM; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PIGMENT EPITHELIUM; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; REVIEW; RISK FACTOR; SCANNING LASER OPHTHALMOSCOPY; SIGNAL TRANSDUCTION; UPREGULATION; UVEITIS;

EID: 84875137211     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.265     Document Type: Review

References (99)

1. Mackenzie W. Practical Treatise on Diseases of the Eye. Longman, Orme, Brown, Green and Longman: London, 1833.
2. Wacker WB, Donoso LA, Kalsow CM, Yankeelov Jr., JA, Organisciak DT. Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina. J Immunol 1977; 119: 1949-1958. (Pubitemid 8232088)
3. Wacker WB, Lipton MM. Experimental allergic uveitis: Homologous retina as uveitogenic antigen. Nature 1965; 206: 253-254.
4. Caspi RR. A look at autoimmunity and inflammation in the eye. J Clin Invest 2010; 120: 3073-3083.
5. Klaver CC, Assink JJ, van Leeuwen R, Wolfs RC, Vingerling JR, Stijnen T et al. Incidence and progression rates of age-related maculopathy: The Rotterdam Study. Invest Ophthalmol Vis Sci 2001; 42: 2237-2241. (Pubitemid 32848852)
6. Dick AD, Okada A, Forrester JV. Practical Manual of Intraocular Inflammation. Informa Health Care: London, 2008.
7. Forrester JV, Okada A, Ben Ezra D. Posterior Segment Intraocular Inflammation: Guidelines. Kugler Publications: The Hague, Netherlands, 1998.
8. Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: A literature survey. Br J Ophthalmol 1996; 80: 844-848. (Pubitemid 26345317)
9. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 2005; 140: 509-516. (Pubitemid 41224845)
10. Furusato E, Shen D, Cao X, Furusato B, Nussenblatt RB, Rushing EJ et al. Inflammatory cytokine and chemokine expression in sympathetic ophthalmia: A pilot study. Histol Histopathol 2011; 26: 1145-1151.
11. Lim WK, Nussenblatt RB, Chan CC. Immunopathologic features of inflammatory coats disease. Arch Ophthalmol 2005; 123: 279-281. (Pubitemid 40189727)
12. Martin DF, Chan CC, de Smet MD, Palestine AG, Davis JL, Whitcup SM et al. The role of chorioretinal biopsy in the management of posterior uveitis. Ophthalmology 1993; 100: 705-714. (Pubitemid 23143893)
13. Caspi RR. Experimental autoimmune uveoretinitis in the rat and mouse. Curr Protoc Immunol 2003, Chapter 15: Unit 15.6: pp 1-20.
14. Forrester JV. Intermediate and posterior uveitis. Chem Immunol Allergy 2007; 92: 228-243. (Pubitemid 47096912)
15. Forrester JV, Borthwick GM. Clinical relevance of S-antigen induced experimental uveoretinitis. Trans Ophthalmol Soc UK 1983; 103(Part 5), 497-502. (Pubitemid 14065931)
16. Caspi RR, Silver PB, Luger D, Tang J, Cortes LM, Pennesi G et al. Mouse models of experimental autoimmune uveitis. Ophthalmic Res 2008; 40: 169-174. (Pubitemid 351562898)
17. Bajenoff M. Stromal cells control soluble material and cellular transport in lymph nodes. Front Immunol 2012; 3: 304.
18. Xu H, Manivannan A, Dawson R, Crane IJ, Mack M, Sharp P et al. Differentiation to the CCR2 inflammatory phenotype in vivo is a constitutive, time-limited property of blood monocytes and is independent of local inflammatory mediators. J Immunol 2005; 175: 6915-6923. (Pubitemid 41598937)
19. Xu H, Manivannan A, Jiang HR, Liversidge J, Sharp PF, Forrester JV et al. Recruitment of IFN-gamma-producing (Th1-like) cells into the inflamed retina in vivo is preferentially regulated by P-selectin glycoprotein ligand 1:P/E-selectin interactions. J Immunol 2004; 172: 3215-3224. (Pubitemid 38263713)
20. Forrester JV, Klaska IP, Yu T, Kuffova L. Uveitis in mouse and man. Int Rev Immunol 2013, (in press).
21. Gupta V, Gupta A, Rao NA. Intraocular tuberculosisYan update. Surv Ophthalmol 2007; 52: 561-587.
22. Forrester JV, Borthwick GM, McMenamin PG. Ultrastructural pathology of S-antigen uveoretinitis. Invest Ophthalmol Vis Sci 1985; 26: 1281-1292. (Pubitemid 15237920)
23. Dua HS, McKinnon A, McMenamin PG, Forrester JV. Ultrastructural pathology of the 'barrier sites' in experimental autoimmune uveitis and experimental autoimmune pinealitis. Br J Ophthalmol 1991; 75: 391-397.
24. Harper FH, Liversidge J, Thomson AW, Forrester JV. Interphotoreceptor retinoid binding protein induced experimental autoimmune uveitis: An immunophenotypic analysis using alkaline phosphatase anti-alkaline phosphatase staining, dual immunofluorescence and confocal microscopy. Curr Eye Res 1992; 11: 129-134.
25. McMenamin PG, Forrester JV, Steptoe RJ, Dua HS. Ultrastructural pathology of experimental autoimmune uveitis. Quantitative evidence of activation and possible high endothelial venule-like changes in retinal vascular endothelium. Lab Invest 1992; 67: 42-55.
26. Xu H, Manivannan A, Liversidge J, Sharp PF, Forrester JV, Crane IJ et al. Involvement of CD44 in leukocyte trafficking at the blood-retinal barrier. J Leukoc Biol 2002; 72: 1133-1141. (Pubitemid 36008883)
27. Broderick C, Hoek RM, Forrester JV, Liversidge J, Sedgwick JD, Dick AD et al. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am J Pathol 2002; 161: 1669-1677. (Pubitemid 35265526)
28. Robertson MJ, Erwig LP, Liversidge J, Forrester JV, Rees AJ, Dick AD et al. Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis. Invest Ophthalmol Vis Sci 2002; 43: 2250-2257. (Pubitemid 34700655)
29. Jiang HR, Wei X, Niedbala W, Lumsden L, Liew FY, Forrester JV et al. IL-18 not required for IRBP peptideinduced EAU: Studies in gene-deficient mice. Invest Ophthalmol Vis Sci 2001; 42: 177-182. (Pubitemid 32059426)
30. Jiang HR, Lumsden L, Forrester JV. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice. Invest Ophthalmol Vis Sci 1999; 40: 3177-3185.
31. Forrester JV, Huitinga I, Lumsden L, Dijkstra CD. Marrowderived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats. Curr Eye Res 1998; 17: 426-437. (Pubitemid 28176909)
32. Hoey S, Grabowski PS, Ralston SH, Forrester JV, Liversidge J. Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism. J Immunol 1997; 159: 5132-5142. (Pubitemid 127471054)
33. Kerr EC, Raveney BJ, Copland DA, Dick AD, Nicholson LB. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J Autoimmun 2008; 31: 354-361.
34. Jiang HR, Hwenda L, Makinen K, Oetke C, Crocker PR, Forrester JV et al. Sialoadhesin promotes the inflammatory response in experimental autoimmune uveoretinitis. J Immunol 2006; 177: 2258-2264. (Pubitemid 44200985)
35. Tu Z, Li Y, Smith D, Doller C, Sugita S, Chan CC et al. Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 2012; 53: 959-966.
36. McMenamin PG, Forrester JV, Steptoe R, Dua HS. Ultrastructural pathology of experimental autoimmune uveitis in the rat. Autoimmunity 1993; 16: 83-93. (Pubitemid 24060868)
37. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32: 593-604.
38. Chen M, Copland DA, Zhao J, Liu J, Forrester JV, Dick AD et al. Persistent inflammation subverts thrombospondin-1-induced regulation of retinal angiogenesis and is driven by CCR2 ligation. Am J Pathol 2012; 180: 235-245.
39. Johnson AR, Justin Milner J, Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 2012; 249: 218-238.
40. Zhang W, Liu H, Al-Shabrawey M, Caldwell RW, Caldwell RB. Inflammation and diabetic retinal microvascular complications. J Cardiovasc Dis Res 2011; 2: 96-103.
41. Busik JV, Tikhonenko M, Bhatwadekar A, Opreanu M, Yakubova N, Caballero S et al. Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med 2009; 206: 2897-2906.
42. Yellowlees Douglas J, Bhatwadekar AD, Li Calzi S, Shaw LC, Carnegie D, Caballero S et al. Bone marrow-CNS connections: Implications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res 2012; 31: 481-494.
43. Minhas G, Morishita R, Anand A. Preclinical models to investigate retinal ischemia: Advances and drawbacks. Front Neurol 2012; 3: 75.
44. Robinson R, Barathi VA, Chaurasia SS, Wong TY, Kern TS. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech 2012; 5: 444-456.
45. Han Z, Guo J, Conley SM, Naash MI. Retinal angiogenesis in the Ins2Akita mouse model of diabetic retinopathy. Invest Ophthalmol Vis Sci, e-pub ahead of print, 6 December 2012; doi: 10.1167/iovs.12-10959.
46. Michaelson IC, Herz N, Lewkowitz E, Kertesz D. Effect of increased oxygen on the development of the retinal vessels; an experimental study. Br J Ophthalmol 1954; 38: 577-587.
47. Ashton N. Oxygen and the growth and development of retinal vessels. in vivo and in vitro studies. The XX Francis I. Proctor Lecture. Am J Ophthalmol 1966; 62: 412-435.
48. Schroder S, Palinski W, Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 1991; 139: 81-100.
49. MacKinnon JR, Knott RM, Forrester JV. Altered L-selectin expression in lymphocytes and increased adhesion to endothelium in patients with diabetic retinopathy. Br J Ophthalmol 2004; 88: 1137-1141. (Pubitemid 39141372)
50. Serra AM, Waddell J, Manivannan A, Xu H, Cotter M, Forrester JV et al. CD11b bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation. Am J Pathol 2012; 181: 719-727.
51. Michaelson IC, Yanko L, Berson D, Ivry M. The reactive phase of diabetic retinopathy and the role of the reticuloendothelial system. Am J Ophthalmol 1974; 78: 400-410.
52. Michaelson IC. Intra-mural new vessels in an occluded retinal vein; a clinical description. Br J Ophthalmol 1948; 32: 164-166.
53. Thakkinstian A, McEvoy M, Chakravarthy U, Chakrabarti S, McKay GJ, Ryu E et al. The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis. Am J Epidemiol 2012; 176: 361-372.
54. Donoso LA, Vrabec T, Kuivaniemi H. The role of complement Factor H in age-related macular degeneration: A review. Surv Ophthalmol 2010; 55: 227-246.
55. Ding X, Patel M, Chan CC. Molecular pathology of agerelated macular degeneration. Prog Retin Eye Res 2009; 28: 1-18.
56. Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1986; 27: 364-371. (Pubitemid 16129922)
57. Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: The involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol 1985; 223: 69-76. (Pubitemid 15051681)
58. Wong WT, Kam W, Cunningham D, Harrington M, Hammel K, Meyerle CB et al. Treatment of geographic atrophy by the topical administration of OT-551: Results of a phase II clinical trial. Invest Ophthalmol Vis Sci 2010; 51: 6131-6139.
59. Hollyfield JG, Perez VL, Salomon RG. A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. Mol Neurobiol 2010; 41: 290-298.
60. Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 2008; 14: 194-198. (Pubitemid 351214555)
61. Kijlstra A, Tian Y, Kelly ER, Berendschot TT. Lutein: more than just a filter for blue light. Prog Retin Eye Res 2012; 31: 303-315.
62. Tauber AI. Metchnikoff and the phagocytosis theory. Nat Rev Mol Cell Biol 2003; 4: 897-901. (Pubitemid 37411727)
63. Medzhitov R, Janeway Jr. CA. An ancient system of host defense. Curr Opin Immunol 1998; 10: 12-15. (Pubitemid 28112072)
64. Medzhitov R, Janeway Jr. CA. Decoding the patterns of self and nonself by the innate immune system. Science 2002; 296: 298-300. (Pubitemid 34303673)
65. Creagh EM, O'Neill LA. TLRs, NLRs and RLRs: A trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 2006; 27: 352-357. (Pubitemid 44038661)
66. O'Neill LA. TLRs Professor Mechnikov, sit on your hat. Trends Immunol 2004; 25: 687-693. (Pubitemid 39457983)
67. Matzinger P. Tolerance danger, and the extended family. Annu Rev Immunol 1994; 12: 991-1045.
68. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: Endogenous activators of dendritic cells. Nat Med 1999; 5: 1249-1255. (Pubitemid 29535601)
69. Guenet B, Danger M, Abbadie L, Lacroix G. Priming effect: Bridging the gap between terrestrial and aquatic ecology. Ecology 2010; 91: 2850-2861.
70. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428-435.
71. Rosenbaum JT, Rosenzweig HL, Smith JR, Martin TM, Planck SR. Uveitis secondary to bacterial products. Ophthalmic Res 2008; 40: 165-168. (Pubitemid 351562897)
72. Getts DR, Turley DM, Smith CE, Harp CT, McCarthy D, Feeney EM et al. Tolerance induced by apoptotic antigencoupled leukocytes is induced by PD-L1 and IL-10-producing splenic macrophages and maintained by T regulatory cells. J Immunol 2011; 187: 2405-2417.
73. Donders FC. Beitrage zur pathologische Anatomie des Auges. Graefes Arch Klin Exp Ophthalmol 1854; 1: 106-118.
74. Sarks SH. Ageing and degeneration in the macular region: A clinico-pathological study. Br J Ophthalmol 1976; 60: 324-341.
75. Yu Y, Reynolds R, Rosner B, Daly MJ, Seddon JM. Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Invest Ophthalmol Vis Sci 2012; 53: 1548-1556.
76. Williams MA, Craig D, Passmore P, Silvestri G. Retinal drusen: Harbingers of age, safe havens for trouble. Age Ageing 2009; 38: 648-654.
77. Friberg TR, Bilonick RA, Brennen P. Is drusen area really so important? An assessment of risk of conversion to neovascular AMD based on computerized measurements of drusen. Invest Ophthalmol Vis Sci 2012; 53: 1742-1751.
78. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H et al. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 2002; 99: 14682-14687. (Pubitemid 35334544)
79. Curcio CA, Johnson M, Rudolf M, Huang JD. The oil spill in ageing Bruch membrane. Br J Ophthalmol 2011; 95: 1638-1645.
80. Rudolf M, Clark ME, Chimento MF, Li CM, Medeiros NE, Curcio CA et al. Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest Ophthalmol Vis Sci 2008; 49: 1200-1209.
81. Forrester JV, Xu H, Kuffova L, Dick AD, McMenamin PG. Dendritic cell physiology and function in the eye. Immunol Rev 2010; 234: 282-304.
82. Xu H, Chen M, Manivannan A, Lois N, Forrester JV. Agedependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell 2008; 7: 58-68.
83. Chen M, Muckersie E, Forrester JV, Xu H. Immune activation in retinal aging: A gene expression study. Invest Ophthalmol Vis Sci 2010; 51: 5888-5896.
84. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR et al. The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited. Prog Retin Eye Res 2010; 29: 95-112.
85. Liu G, Duan K, Ma H, Niu Z, Peng J, Zhao Y et al. An instructive role of donor macrophages in mixed chimeras in the induction of recipient CD4 Foxp3 Treg cells. Immunol Cell Biol 2011; 89: 827-835.
86. Lotery A, Trump D. Progress in defining the molecular biology of age related macular degeneration. Hum Genet 2007; 122: 219-236. (Pubitemid 47616531)
87. Gauthier Y, Cario Andre M, Taieb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 2003; 16: 322-332 (Pubitemid 36950564)
88. Cherepanoff S, McMenamin P, Gillies MC, Kettle E, Sarks SH. Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br J Ophthalmol 2010; 94: 918-925.
89. Kokkinopoulos I, Shahabi G, Colman A, Jeffery G. Mature peripheral RPE cells have an intrinsic capacity to proliferate; a potential regulatory mechanism for agerelated cell loss. PLoS One 2011; 6: E18921.
90. Forrester JV, McMenamin PG, Holthouse I, Lumsden L, Liversidge J. Localization and characterization of major histocompatibility complex class II-positive cells in the posterior segment of the eye: Implications for induction of autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 1994; 35: 64-77. (Pubitemid 24046829)
91. Gordon S, Hamann J, Lin HH, Stacey M. F4/80 and the related adhesion-GPCRs. Eur J Immunol 2011; 41: 2472-2476.
92. Wen H, Ting JP, O'Neill LA. A role for the NLRP3 inflammasome in metabolic diseasesYdid Warburg miss inflammation? Nat Immunol 2012; 13: 352-357
93. Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci USA 2009; 106: 870-875.
94. Kerrigan AM, Brown GD. Phagocytes: fussy about carbs. Curr Biol 2011; 21: R500-2.
95. Doyle SL, Campbell M, Ozaki E, Salomon RG, Mori A, Kenna PF et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med 2012; 18: 791-798.
96. Tarallo V, Hirano Y, Gelfand BD, Dridi S, Kerur N, Kim Y et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 2012; 149: 847-859.
97. Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 2012; 13: 255-263.
98. Wang AL, Lukas TJ, Yuan M, Du N, Tso MO, Neufeld AH et al. Autophagy, exosomes and drusen formation in age-related macular degeneration. Autophagy 2009; 5: 563-564.
99. Wang AL, Lukas TJ, Yuan M, Du N, Tso MO, Neufeld AH et al. Autophagy and exosomes in the aged retinal pigment epithelium: possible relevance to drusen formation and age-related macular degeneration. PLoS One 2009; 4: E4160.